A study confirms or newly identifies 13 genes that appear to play a role in susceptibility to infection or that affect the severity of illness.
Author: Karen Weintraub, USA TODAY
Spirituality and sense of awe seem to be hard-wired into our brains, researchers find
Researchers found spirituality appears to be focused on a specific circuit in part of the brain also linked to feelings of pain, fear and compassion.
‘It isn’t over for us’: For those with weakened immune systems, COVID-19 vaccines don’t mean the end of the pandemic
For those with compromised immune systems, health experts say ‘get vaccinated, act unvaccinated,’ as vaccines may not protect well against COVID-19.
The same mRNA technology used in COVID-19 vaccines could help treat cancer
Fighting COVID-19 proved a boon to cancer research. Here’s how scientists are using the same mRNA technology to attack tumors.
Why it’s been relatively easy to vaccinate against COVID-19 compared to HIV or cancer
Why has it been so easy to vaccinate against COVID-19 when other medical problems remain intractable? Biology.
It’s been 40 years since the first reported cases of AIDS. While treatments have come a long way, a vaccine remains elusive.
The parallels between AIDS/HIV and COVID-19 and the virus that causes it are stark. But the differences are striking, too.
‘Life-altering:’ As millions cope with smell loss from COVID, researchers find new explanations and possible treatments
Smell loss afflicts the majority of those with COVID. A new understanding is emerging about what causes it, and eventually, how it might be treated.
CDC reports 13 additional cases of blood clots linked to J&J COVID-19 vaccine. All happened before 11-day pause in its use.
The newly revealed cases all occurred in people before the government’s 11-day pause in J&J’s single-dose vaccine last month.
FDA authorizes Pfizer-BioNTech COVID-19 vaccine for younger teens, moving US ‘closer to returning to a sense of normalcy’
The Food and Drug Administration authorized Pfizer’s COVID-19 vaccine for 12-to 15-year-olds, possibly starting as soon as Thursday.
‘Game-changer’ cancer drug celebrates 20 years. Gleevec turned a death sentence into a chronic disease for many.
The cancer drug Gleevec, which ushered a new era in cancer care focusing on a tumor’s characteristics not its location, marks its 20th anniversary.